Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

PHASE3RecruitingINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

July 30, 2024

Conditions

Dry Eye Disease

Interventions

DRUG

ST-100 (vezocolmitide)

ST-100 (vezocolmitide) Ophthalmic Solution 60 μg/ml

DRUG

Vehicle

Vehicle Ophthalmic Solution

Trial Locations (1)

RECRUITING

Total Eye Care, PA, Memphis

All Listed Sponsors

collaborator

Stuart Therapeutics, Inc.

INDUSTRY

lead

ORA, Inc.

INDUSTRY